BeOne Medicines Shifts to Fully Electronic Distribution of Corporate Communications

Bulletin Express

5 hours ago

On 10 September 2026, BeOne Medicines Ltd (BeOne Medicines) issued a reminder to its non-registered shareholders confirming the company’s transition to electronic dissemination of all future corporate communications.

The Switzerland-incorporated biopharmaceutical group reiterated that, unless otherwise required, materials such as interim and annual reports, general-meeting notices, proxy forms, circulars and listing documents will be provided exclusively in digital format. Identical English and Chinese versions will be accessible on both the corporate investor-relations site (https://hkexir.beonemedicines.com) and the HKEXnews platform (www.hkexnews.hk).

BeOne Medicines highlighted that it will no longer issue email alerts or mail printed copies, with two exceptions mandated by applicable regulations: 1) Proxy materials for shareholder meetings; and 2) U.S. Securities and Exchange Commission filings, including the Form 10-K and related notices.

Shareholders who prefer hard-copy documents can submit a completed reply form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, or send a request via email to BeOne.ecom@computershare.com.hk. The registrar’s enquiry hotline is (852) 2862 8688, available on Hong Kong business days from 9:00 a.m. to 6:00 p.m.

The company reminded investors that, in the absence of email notifications, they should actively monitor the designated websites to stay informed of new corporate disclosures.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1160326055"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160326055\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160326055?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160326055","market":"us","top_or_hot":-1,"title":"BeOne Medicines Shifts to Fully Electronic Distribution of Corporate Communications","media":"Bulletin Express","content":"<p>On 10 September 2026, BeOne Medicines Ltd (BeOne Medicines) issued a reminder to its non-registered shareholders confirming the company’s transition to electronic dissemination of all future corporate communications.</p>\n<p>The Switzerland-incorporated biopharmaceutical group reiterated that, unless otherwise required, materials such as interim and annual reports, general-meeting notices, proxy forms, circulars and listing documents will be provided exclusively in digital format. Identical English and Chinese versions will be accessible on both the corporate investor-relations site (https://hkexir.beonemedicines.com) and the HKEXnews platform (www.hkexnews.hk).</p>\n<p>BeOne Medicines highlighted that it will no longer issue email alerts or mail printed copies, with two exceptions mandated by applicable regulations: \n1) Proxy materials for shareholder meetings; and  \n2) U.S. Securities and Exchange Commission filings, including the Form 10-K and related notices.</p>\n<p>Shareholders who prefer hard-copy documents can submit a completed reply form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, or send a request via email to BeOne.ecom@computershare.com.hk. The registrar’s enquiry hotline is (852) 2862 8688, available on Hong Kong business days from 9:00 a.m. to 6:00 p.m.</p>\n<p>The company reminded investors that, in the absence of email notifications, they should actively monitor the designated websites to stay informed of new corporate disclosures.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Shifts to Fully Electronic Distribution of Corporate Communications</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Shifts to Fully Electronic Distribution of Corporate Communications\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-10 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 10 September 2026, BeOne Medicines Ltd (BeOne Medicines) issued a reminder to its non-registered shareholders confirming the company’s transition to electronic dissemination of all future corporate communications.</p>\n<p>The Switzerland-incorporated biopharmaceutical group reiterated that, unless otherwise required, materials such as interim and annual reports, general-meeting notices, proxy forms, circulars and listing documents will be provided exclusively in digital format. Identical English and Chinese versions will be accessible on both the corporate investor-relations site (https://hkexir.beonemedicines.com) and the HKEXnews platform (www.hkexnews.hk).</p>\n<p>BeOne Medicines highlighted that it will no longer issue email alerts or mail printed copies, with two exceptions mandated by applicable regulations: \n1) Proxy materials for shareholder meetings; and  \n2) U.S. Securities and Exchange Commission filings, including the Form 10-K and related notices.</p>\n<p>Shareholders who prefer hard-copy documents can submit a completed reply form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, or send a request via email to BeOne.ecom@computershare.com.hk. The registrar’s enquiry hotline is (852) 2862 8688, available on Hong Kong business days from 9:00 a.m. to 6:00 p.m.</p>\n<p>The company reminded investors that, in the absence of email notifications, they should actively monitor the designated websites to stay informed of new corporate disclosures.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1160326055","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160326055","pubTimestamp":1789033394,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 10 September 2026, BeOne Medicines Ltd (BeOne Medicines) issued a reminder to its non-registered shareholders confirming the company’s transition to electronic dissemination of all future...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines 转向企业通讯的全电子分发","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On 10 September 2026, BeOne Medicines Ltd (BeOne Medicines) issued a reminder to its non-registered shareholders confirming the company’s transition to electronic dissemination of all future corporate communications.\nThe Switzerland-incorporated biopharmaceutical group reiterated that, unless otherwise required, materials such as interim and annual reports, general-meeting notices, proxy forms, circulars and listing documents will be provided exclusively in digital format. Identical English and Chinese versions will be accessible on both the corporate investor-relations site (https://hkexir.beonemedicines.com) and the HKEXnews platform (www.hkexnews.hk).\nBeOne Medicines highlighted that it will no longer issue email alerts or mail printed copies, with two exceptions mandated by applicable regulations: \n1) Proxy materials for shareholder meetings; and  \n2) U.S. Securities and Exchange Commission filings, including the Form 10-K and related notices.\nShareholders who prefer hard-copy documents can submit a completed reply form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, or send a request via email to BeOne.ecom@computershare.com.hk. The registrar’s enquiry hotline is (852) 2862 8688, available on Hong Kong business days from 9:00 a.m. to 6:00 p.m.\nThe company reminded investors that, in the absence of email notifications, they should actively monitor the designated websites to stay informed of new corporate disclosures.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}